Dar Zavain bought RXRX
October 1, 2025 · Form 4 insider transaction
Dar Zavain bought 2,941 shares of Recursion Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
2,941
Price
$0.00
Total value
N/A
InsiderDar Zavain
Role—
SecurityClass A Common Stock
Transaction codeA: Grant or award
Transaction dateOctober 1, 2025
Filing dateOctober 3, 2025
Shares owned after138,758
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The shares were issued pursuant to the Issuer's Outside Director Compensation Policy.